CSPG4 and neoplasm: In multivariate analysis, the “CSPG4-high” group (HR=3.47, 95% CI 1.73–6.95, p=4.59E−04) and higher pathological tumor size (HR=1.05, 95% CI 1.01–1.09, p=1.98E−02) remained significant, suggesting independent poor-prognosis value.